Genomic medicine developer Precision Biosciences plans to raise up to $100m in an upcoming IPO that could hand exits to Duke University and corporates Amgen, EMS and Baxter.

Nightstar Therapeutics, based on Oxford research, stands to receive $800m from Biogen in an acquisition deal that comes a year and a half after completing a $75m IPO.

Process management technology developer Iconpro was founded out of RWTH Aachen last year and is targeting its services at the manufacturing sector.

University of Utah’s TVC commercialisation office is to open a new incubator with Recursion, itself a Utah spinout, to provide facilities including wet lab and co-working space.

Ghent-founded indoor position technology business Pozyx has amassed more than $1.5m having recently completed the launch of its initial product range.

Fibronox spun out from University of Arizona’s College of Medicine – Tucson in 2017 to deliver Nox4-inhibiting drugs for fibrotic disorders including lung fibrosis.

Tulane University and LSU Health Sciences Center have selected New Orleans BioInnovation Center to administer life sciences accelerator services.

Sarepta Therapeutics exercised its option to acquire Nationwide Children’s gene therapy spinout Myonexus Therapeutics after paying at least $60m for the right in May 2018.

Stephen Larter has become Calgary’s associate vice-president for research and innovation, adding to his duties as chief scientist of the university’s CDL-Rockies accelerator for energy startups.

ICL will restore internal tech transfer activities from its Imperial White City Incubator, in the process ending its arrangement with commercialisation firm IP Group.